Fig. 8
From: Optimizing drug combination and mechanism analysis based on risk pathway crosstalk in pan cancer

Survival curves of drug combination targets for four cancers. (a) COAD; (b) STAD; (c) KIRP; (d) THYM.
From: Optimizing drug combination and mechanism analysis based on risk pathway crosstalk in pan cancer

Survival curves of drug combination targets for four cancers. (a) COAD; (b) STAD; (c) KIRP; (d) THYM.